Lilly said in an email that while both target metabolic disease, tirzepatide is a GIP/GLP-1 dual agonist injectable, whereas orforglipron is a selective, oral GLP-1 receptor agonist
Schedule your appointment today.
Effective April 22, 2026, BPC-157 was removed from Category 2 (the bulks substances list flagged as raising significant safety concerns)
Bisphenol P exposure in C57BL/6 mice caused gut microbiota dysbiosis and induced intestinal barrier disruption via LPS/TLR4/NF-B signaling pathway
Semaglutide works on one hormone pathway (GLP-1 receptor), while tirzepatide works on two-hormone pathways (GLP-1 and GIP receptor)
By optimizing nutrition, reducing stress, and supporting scalp health , individuals can prevent excessive hair thinning and promote regrowth